# PERTZYE

NDC: 59767-024
Generic name: pancrelipase
Labeler / Manufacturer: Digestive Care, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Biologic License Application
Dosage form: CAPSULE, DELAYED RELEASE
Routes: ORAL
Marketing started: 20170713

FDA application: BLA022175

## Active ingredients

- PANCRELIPASE AMYLASE: 90750 [USP'U]/1
- PANCRELIPASE LIPASE: 24000 [USP'U]/1
- PANCRELIPASE PROTEASE: 86250 [USP'U]/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"59767-024"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=59767-024
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=481eec00-9abf-11dd-b71c-0002a5d5c51b